help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nelson, D. H.
Right arrow Articles by Brady, R. O.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nelson, D. H.
Right arrow Articles by Brady, R. O.

Journal of Clinical Endocrinology & Metabolism, Vol 54, 292-295, Copyright © 1982 by Endocrine Society

ARTICLES

Dexamethasone-induced change in the sphingomyelin content of human polymorphonuclear leukocytes in vitro

DH Nelson, DK Murray and RO Brady

Human polymorphonuclear leukocytes were incubated with 8 x 10(-9) M dexamethasone for 2 h. A significant increase in the sphingomyelin content of the cells was found when 8 x 10(-8) M dexamethasone was used, with lesser changes being noted when the concentration was increased or decreased from this level. The increase in the phospholipid was blocked by the addition of cycloheximide to the incubation. Concurrent with the increase in sphingomyelin, an increase in sphingomyelinase was demonstrated. This increased enzymatic activity may have occurred secondary to the increase in substrate or may be involved in the reverse reaction, whereby phosphorylcholine and ceramide combine to form sphingomyelin. Other studies have demonstrated an effect of corticosteroids to suppress the production of superoxide anion and the importance of a membrane oxidase in the production of the anion. An action of dexamethasone to both suppress superoxide anion production and increase sphingomyelin content suggests a possible effect of the lipid changes upon the oxidase responsible for the production of the anion.


This article has been cited by other articles:


Home page
 DiabetesHome page
S. A. Summers and D. H. Nelson
A Role for Sphingolipids in Producing the Common Features of Type 2 Diabetes, Metabolic Syndrome X, and Cushing's Syndrome
Diabetes, March 1, 2005; 54(3): 591 - 602.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
M. G. Cifone, G. Migliorati, R. Parroni, C. Marchetti, D. Millimaggi, A. Santoni, and C. Riccardi
Dexamethasone-Induced Thymocyte Apoptosis: Apoptotic Signal Involves the Sequential Activation of Phosphoinositide-Specific Phospholipase C, Acidic Sphingomyelinase, and Caspases
Blood, April 1, 1999; 93(7): 2282 - 2296.
[Abstract] [Full Text] [PDF]

Home page
 ScienceHome page
Y. Hannun and R. Bell
Functions of sphingolipids and sphingolipid breakdown products in cellular regulation
Science, January 27, 1989; 243(4890): 500 - 507.
[Abstract] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1982 by The Endocrine Society